Kaitlyn Kosko

DocwireNews

A genomic nasal swab test can determine lung cancer risk, with high accuracy, in individuals who smoke or have previously smoked, according to a study led by Carla R. Lamb, MD.Lamb et al used machine learning to train a classifier using genomic and clinical features on 1120 patients with either benign or malignant pulmonary nodules. The classifier was designed to yield low-, intermediate-, and high-risk categories.&ldquo;Accurate assessment of the probability of lung cancer is critical in patients with pulmonary nodules to help guide decision-making,&rdquo; the researchers wrote.The nasal epithelial cells used to develop the classifier were from patients with a pulmonary nodule that was 30 mm or less. An independent set of 312 patients with lung cancer was used to validate the classifier. Of these patients, 63 had a history of cancer other than in the lung.Researchers found that the classifier showed a specificity of 90% and a sensitivity of 58% in the high-risk category. For low-risk classification, specificity was 42% and sensitivity was 96%. Furthermore, sensitivity was similar across stages of NSCLC.In the patients with a prior cancer history, an analysis of the classifier showed similar performance. The same was true for patients with light versus heavy smoking burden and patients eligible for lung cancer screening versus those who were not.&ldquo;Classifier-guided decision-making could lead to fewer diagnostic procedures in patients without cancer and more timely treatment in patients with lung cancer,&rdquo; the researchers concluded.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Genomic Nasal Swab to Help Determine Risk of Lung Cancer

Lung Cancer

A genomic nasal swab test can determine lung cancer risk in individuals who smoke or have previously smoked. 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe